CRF spotlights Candle, a new CHM research hub

The Choroideremia Research Foundation is promoting Candle, a patient-built website that centralizes clinical trials, publications and AI-assisted research tools for people affected by choroideremia. The launch is meant to make CHM research easier to find, read and use while improving accessibility for visually impaired users.

Why it matters: - Candle gives the choroideremia community one searchable place to track research that is usually spread across trial registries, journals and other databases. - The platform is built to help patients, families, researchers and clinicians follow CHM progress without having to sort through technical sources on their own. - CRF is positioning the tool as a practical way to improve access to information for a rare disease with no approved treatments.

What happened: - The Choroideremia Research Foundation highlighted Candle, a new online resource hub for choroideremia research. - CHMer and Purdue University computer science student Tanish Misra developed the platform after struggling to track CHM research across fragmented sources. - Misra said the project began as a personal effort to stay informed about his own condition and grew into a tool for the broader CHM community. - CRF added Candle to its website under the Research section at the CHM resource hub. - Candle is open source and available at candleforchm.org.

The details: - Candle’s mission statement is: “A small light for a long journey.” - The platform’s Trials section pulls CHM-related studies from ClinicalTrials.gov. - Trials includes structured summaries, plain-language explanations and an interactive timeline showing CHM research over time. - The Literature section organizes peer-reviewed publications from PubMed. - Literature includes structured summaries, key metadata and links to related clinical trials when available. - The Ask feature is a retrieval-augmented AI assistant that answers questions only from indexed CHM trials and literature inside Candle. - Every Ask response includes citations to source material. - Candle does not provide medical advice, diagnoses or treatment recommendations. - A daily automated pipeline updates the platform by ingesting new research data, generating embeddings and refreshing summaries without manual intervention.

Between the lines: - The project reflects a shift from raw research access to interpretation and usability, especially for people who are not scientific specialists. - Accessibility became a central design issue after Misra shared the platform with CRF leadership and community members who rely on screen readers. - Brian Counter, Lin Ogg and Sheldon Lewis tested Candle with NVDA and JAWS and identified usability problems that standard testing missed. - Their feedback led to improved screen reader labeling, better keyboard navigation, stronger focus management, modal fixes, clearer accessibility announcements, expanded filtering and broader consistency upgrades. - CRF Chief Scientific Officer Dr. Mike McConnell said the safeguards matter because the system is meant to support understanding, not replace medical guidance. - The AI feature was rebuilt after testing showed early versions could drift into recommendation-style responses. - Candle now uses stricter safeguards, broader detection patterns and post-processing checks to keep answers informational and citation-based. - The Ask interface also now includes clearer scope explanations and example prompts.

What’s next: - Candle will continue to evolve based on community feedback and ongoing collaboration with CRF. - The platform is expected to remain focused on CHM research content while expanding usability and trust features as it matures.

The bottom line: - Candle turns scattered CHM research into a patient-built, accessible and citation-backed tool designed to help the community follow the science more easily.